Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Rapid Blood Tests Expected to Have a Sizable Market Share; Heart Attack Diagnostics Market to Reflect a CAGR Of 7.1% through 2032: Fact.MR Study

Published

on

United States, Rockville, MD, May 12, 2022 (GLOBE NEWSWIRE) — During the projected period, the heart attack diagnostics market is estimated to grow at a 7.1% CAGR, from US$ 11.2 Billion by 2022 to US$ 22.2 Billion by 2032.

The COVID-19 pandemic has substantially influenced the market for heart attack diagnoses. People with heart disorders are more likely to develop the virus, especially those prone to heart attacks, and there is a substantial risk of mortality if the infection is not detected in time. Furthermore, several of the early symptoms of COVID-19 are similar to heart attacks, such as chest discomfort, nausea, exhaustion, and difficulty breathing.

The rise in cases of coronary heart disease, technological advancements in ECG devices such as handheld and portable, an increase in geriatric populations, rising obesity and tobacco smoking, a shift toward an unhealthy lifestyle, and favourable government regulations regarding monitoring devices are all factors driving the growth of the heart attack diagnostics market.

Want A Detailed Understanding of Computerized Cardiac Tomography Demand Market Functioning? Request for a Sample Here

https://www.factmr.com/connectus/sample?flag=S&rep_id=7322

Furthermore, an increase in healthcare expenditure, collaborations and partnerships between key players to facilitate drug development; an increase in R&D activities; the launch of novel devices; and technological development are factors driving the growth of the heart attack diagnostics market.

However, the greater cost of diagnostic instruments, a shortage of experienced professionals, and the low Medicare reimbursement granted for mobile cardiac outpatient telemetry electrocardiogram (ECG) would impede the growth of the heart attack diagnostics market.

The increasing prevalence of cardiovascular illnesses, the ageing of the population, and the rising need for advanced cardiovascular therapy would drive the expansion of the heart attack diagnostics market.

Furthermore, growing healthcare spending, collaborations and partnerships among major players, increased R & D, launches of innovative created devices and technical improvements are some of the factors driving the growth of the heart attack diagnostics market.

For Comprehensive Insights of Heart Attack Diagnosis Blood Tests Demand market Ask An Analyst Here @

https://www.factmr.com/connectus/sample?flag=AE&rep_id=7322

Key Takeaways:

  • In the test sector, blood tests from the heart attack diagnostics market are anticipated to flourish at the quickest CAGR of 6.8% through 2032.
  • With a CAGR of 6.7% through 2032, Hospitals are predicted to grow significantly in the end-use sector of the heart attack diagnostics market.
  • The market size for heart attack diagnostics market in the United States is expected to reach US$ 7.7 Billion by 2032, growing at a CAGR of 6.8% during the forecast period.
  • United Kingdom is anticipated to reach a market size of US$ 926.5 Million in Heart attack diagnostics by 2032, with a CAGR of 6.1% during the forecast period.
  • China’s Heart attack diagnostics market is anticipated to be worth US$ 1.6 million by 2032, with a CAGR of 6.4% over the forecast period.
  • Japan is expected to have a market size for Heart attack diagnostics of US$ 1.3 Billion by 2032, with a CAGR of 5.4% during the forecast period.
  • By 2032, South Korea is expected to reach a market size of US$ 839.6 Million in heart attack diagnostics, with a CAGR of 5% during the forecast period.

To Get All-In Insights On The Regional Landscape Of The Market @

https://www.factmr.com/checkout/7322

Competitive Landscape:

The heart attack diagnostics market is projected to be extremely competitive, with numerous prominent competitors. New quick and portable (flexible) blood and enzyme-based diagnostics have the potential to dominate the heart attack diagnostics market and drive innovation in these areas.

Advancements in ECG technology may be game changers for low-income nations and severe heart-related disorders. Siemens Healthcare GmbH, Schiller AG, GE Healthcare, Hitachi Medical Systems, and F Hoffmann-La Roche Ltd are among the prominent companies.

Recent Development:

  • In April 2021, Roche unveiled a set of five new intended uses for two critical cardiac biomarkers, highly sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test, utilising Elecsys® technology (NT-proBILLIONP).
  • The European Union authorised the artificial intelligence-based CaRi-Heart Technology in March 2021 to identify and forecast the danger of a serious heart attack years before it occurs. The British Heart Foundation and Caristo Diagnostics collaborated to create the CaRi-Heart Technology.

Get Customization on this Sales of ECG-based Test Demand Report for Specific Research Solutions at

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7322

Geographically, the United States was found to have the largest heart attack diagnostics market due to the region’s increasing incidence rate and substantial research and development efforts. Countries such as the United States and Canada have been effective in the demand for heart attack diagnostics, which will assist in the region’s heart attack diagnostics market expansion.

The availability of well-equipped healthcare infrastructure, encouraging government measures to introduce heart attack diagnostics, and an ever-improving reimbursement environment will drive heart attack diagnostics market expansion.

Europe was found to be the second biggest market in heart attack diagnostics due to improved healthcare procedures and the installation of deep healthcare concerns in the region due to the increased risk of a heart attack in older patients. The Asia Pacific region is predicted to expand the quickest during the projection period.

The rising number of patients suffering from cardiovascular illnesses, the high burden of patients in densely populated nations such as India, and the region’s increasing desire for enhanced diagnostics are key factors driving the heart attack diagnostics market in the Asia Pacific.

China and India are the region’s fastest-growing economies, which will drive market growth for total heart attack diagnostics.

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

Which Market Trends are Driving Demand for Throat Lozenges? – Another factor boosting the global throat lozenges market is the increased desire for natural and herbal goods. Throat lozenges are frequently made with herbs like ginger or honey, which give a soothing treatment for a sore throat.

Which Key Aspects are Bolstering Demand Growth of Microplate Systems? – Microplate systems have evolved during the last 60 years as well. Researchers are constantly attempting to improve the technology utilized in microplates, resulting in improved products on the market.

Will Rising Prevalence of Breast Cancer Drive Doxorubicin Demand? – The use of Doxil for metastatic breast cancer and the use of Doxil for chemotherapy in breast cancer has increased in recent years and this trend will be prevalent across the forecast period as well which will subsequently drive doxorubicin shipments through 2026.

Which Key Dynamics are Boosting Sales of Tumor Necrosis Factor Inhibitors? – The global population is increasingly ageing, especially in developed countries like the United States, Japan, and Western Europe. Developed countries have a higher rate of ageing than undeveloped countries.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Mahendra Singh

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

Email: [email protected]

Tel: +1 (628) 251-1583

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading

Trending